Brain Research Bulletin 75 (2008) 648–654
Research report
Differences between normal and alpha-synuclein overexpressing
SH-SY5Y neuroblastoma cells after A(1-42) and NAC treatment
´
Akos Hunya
a,∗
, Istv´ an F ¨ oldi
a,1
, Viktor Szegedi
a,2
, Katalin So ´ os
a,3
, M´ arta Zar´ andi
a,3
,
Antal Szab ´ o
a,1
, D´ enes Z´ adori
a,1
, Botond Penke
a,b,4
, Zsolt L. Datki
b,1
a
Department of Medical Chemistry, University of Szeged, Szeged, Hungary
b
Supramolecular Research Group, Hungarian Academy of Sciences, Szeged, Hungary
Received 4 June 2007; received in revised form 27 September 2007; accepted 22 October 2007
Available online 20 November 2007
Abstract
Alpha-synuclein (SN) plays a major role in numerous neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease.
Intracellular inclusions containing aggregated SN have been reported in Alzheimer’s and Parkinson’s affected brains. Moreover, a proteolytic
fragment of SN, the so-called non-amyloid component of Alzheimer’s disease amyloid (NAC) was found to be an integral part of Alzheimer’s
dementia related plaques. Despite the extensive research on this topic, the exact toxic mechanism of SN remains elusive. We have taken the
advantage of an SN overexpressing SH-SY5Y cell line and investigated the effects of classical apoptotic factors (e.g. H
2
O
2
, amphotericin B
and ruthenium red) and aggregated disease-related peptides on cell viability compared to wild type neuroblastoma cells. It was found that SN
overexpressing cells are more sensitive to aggregated peptides treatment than normal expressing counterparts. In contrast, cells containing elevated
amount of SN were less vulnerable to classical apoptotic stressors than wild type cells. In addition, SN overexpression is accompanied by
altered phenotype, attenuated proliferation kinetics, increased neurite arborisation and decreased cell motility. Based on these results, the SN
overexpressing cell lines may represent a good and effective in vitro model for Alzheimer’s and Parkinson’s disease.
© 2007 Elsevier Inc. All rights reserved.
Keywords: Alpha-synuclein; Beta-amyloid; NAC; SH-SY5Y; Alzheimer’s disease; Parkinson’s disease
1. Introduction
The central pathological feature of Parkinson’s disease (PD)
is the accumulation and aggregation of a synaptic protein, alpha-
synclein (SN). Several findings underlie its main role, such
as mutations in SN are associated with dominantly inher-
∗
Corresponding author at: H-6720 Szeged, Szikra utca 2, Hungary.
Tel.: +36 62 546853; fax.: +36 62 546 826.
E-mail addresses: akos.hunya@gmail.com (
´
A. Hunya),
istvanfoldi82@yahoo.com (I. F ¨ oldi), szegv@yahoo.com (V. Szegedi),
soska@mdche.szote.u-szeged.hu (K. So ´ os),
zarandimarta@yahoo.com (M. Zar´ andi), ertpar@freemail.hu (A. Szab´ o),
zadorid@freemail.hu (D. Z´ adori),
pbotond@mdche.szote.u-szeged.hu (B. Penke),
datkiz@mdche.szote.u-szeged.hu (Z.L. Datki).
1
Tel.: +36 62 546853.
2
Tel.: +36 62 546854.
3
Tel.: +36 62 545140.
4
Tel.: +36 62 545 135.
ited PD and SN was found to be the predominant protein in
Lewy bodies [20,32,36]. Moreover, SN fibrillization appears
to be a major event in other neurodegenerative diseases, such
as multiple system atrophy, where SN is part of glial cyto-
plasmic inclusions [37], and it is associated with the neuronal
intranuclear inclusions of Huntington’s disease [5,15]. SN may
even participate in the pathogenesis of Alzheimer’s disease
(AD), because intracellular inclusions containing aggregated
SN have been reported in Alzheimer’s affected brains [19,28].
In addition, a proteolytic fragment of SN, the so-called non-
amyloid component of Alzheimer’s disease amyloid (NAC) was
described as an integral part of plaques in demented patients [29].
The normal physiologic role of SN is under extensive
research. It was cloned [38] and found to be a human homolog
of the Torpedo ray synuclein, which had been previously iden-
tified in synaptic vesicle preparations [27]. Taken its abundant
expression in the nervous system and its close association with
presynaptic vesicles [7,17], a role in vesicle refilling was sug-
gested [1]. Moreover, SN undergoes a marked conformational
0361-9230/$ – see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.brainresbull.2007.10.035